Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8730271, 6 pages
https://doi.org/10.1155/2017/8730271
Research Article

Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents

1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China
2Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China

Correspondence should be addressed to Junbo Ge; nc.hs.latipsoh-sz@2obnuj.eg

Received 12 December 2016; Accepted 20 February 2017; Published 8 March 2017

Academic Editor: Ramazan Akdemir

Copyright © 2017 Jiasheng Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Natsuaki, T. Morimoto, Y. Furukawa et al., “Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent long-term (5-7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2,” Circulation: Cardiovascular Interventions, vol. 7, no. 2, pp. 168–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Nakazawa, F. Otsuka, M. Nakano et al., “The pathology of neoatherosclerosis in human coronary implants: bare-metal and drug-eluting stents,” Journal of the American College of Cardiology, vol. 57, no. 11, pp. 1314–1322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Leopold, “Neoatherosclerosis: another consequence of endothelial dysfunction?” Circulation: Cardiovascular Interventions, vol. 7, no. 5, pp. 635–637, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Yang, Y. Zeng, C. Zhang et al., “The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent,” Biomaterials, vol. 34, no. 6, pp. 1635–1643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Katsaros, S. P. Kastl, K. A. Krychtiuk et al., “An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents,” EuroIntervention, vol. 10, no. 2, pp. 224–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Kazmierczak, S. Grajek, J. Kowal et al., “Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 15, pp. 2169–2175, 2014. View at Google Scholar · View at Scopus
  7. M. Habara, M. Terashima, K. Nasu et al., “Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study,” European Heart Journal Cardiovascular Imaging, vol. 14, no. 3, pp. 276–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Ramos, P. Napoleão, M. Selas et al., “Prognostic value of vegf in patients submitted to percutaneous coronary intervention,” Disease Markers, vol. 2014, Article ID 135357, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Anderson, C. D. Adams, E. M. Antman et al., “ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/Non–ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine,” Circulation, vol. 116, no. 7, pp. e148–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Mehran, G. Dangas, A. S. Abizaid et al., “Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome,” Circulation, vol. 100, no. 18, pp. 1872–1878, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Third universal definition of myocardial infarction,” Circulation, vol. 126, no. 16, pp. 2020–2035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ohtani, K. Egashira, K.-I. Hiasa et al., “Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells,” Circulation, vol. 110, no. 16, pp. 2444–2452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Khurana, Z. Zhuang, S. Bhardwaj et al., “Angiogenesis-dependent and independent phases of intimal hyperplasia,” Circulation, vol. 110, no. 16, pp. 2436–2443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Hutter, F. E. Carrick, C. Valdiviezo et al., “Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury,” Circulation, vol. 110, no. 16, pp. 2430–2435, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. H. Choi, S. N. Kang, S. M. Kim et al., “Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization,” Colloids and Surfaces B: Biointerfaces, vol. 141, pp. 602–610, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Iijima, T. Araki, Y. Nagashima et al., “Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation,” International Journal of Cardiology, vol. 168, no. 3, pp. 2588–2592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. G. Stefanini, R. A. Byrne, P. W. Serruys et al., “Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials,” European Heart Journal, vol. 33, no. 10, pp. 1214–1222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Niccoli, R. A. Montone, G. Ferrante, and F. Crea, “The evolving role of inflammatory biomarkers in risk assessment after stent implantation,” Journal of the American College of Cardiology, vol. 56, no. 22, pp. 1783–1793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Yahagi, F. Otsuka, K. Sakakura et al., “Pathophysiology of superficial femoral artery in-stent restenosis,” Journal of Cardiovascular Surgery, vol. 55, no. 3, pp. 307–323, 2014. View at Google Scholar · View at Scopus
  20. D. Li, C. Zhang, F. Song, I. Lubenec, Y. Tian, and Q. H. Song, “VEGF regulates FGF-2 and TGF-β1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration,” Microvascular Research, vol. 77, no. 2, pp. 134–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Constantino Rosa Santos, C. Miguel, I. Domingues et al., “VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing,” Experimental Cell Research, vol. 313, no. 8, pp. 1561–1574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Nakata, K. Fujii, M. Fukunaga et al., “Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents,” Catheterization and Cardiovascular Interventions, vol. 88, no. 3, pp. 350–357, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Solinas, G. Dangas, A. J. Kirtane et al., “Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention,” American Journal of Cardiology, vol. 102, no. 3, pp. 311–315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Cosgrave, G. Melzi, G. G. L. Biondi-Zoccai et al., “Drug-eluting stent restenosis. The pattern predicts the outcome,” Journal of the American College of Cardiology, vol. 47, no. 12, pp. 2399–2404, 2006. View at Publisher · View at Google Scholar · View at Scopus